Tag Archives: FDA approved
Biosimilar: Expansion of pharmaceutical industry
Innovations of new drugs in the pharmaceutical industry, like biosimilars, are opening new opportunities for the pharmaceutical industry and a wide […]
ikrisuser
February 16, 2023
US FDA Approves Tecvayli® (Teclistamab-cqyv) for Relapsed/Refractory Multiple Myeloma (RRMM)
On October 25, 2022, the US FDA granted accelerated approval to Tecvayli® (teclistamab-cqyv, Janssen Biotech, Inc.) for adult patients with […]
ikrisuser
October 28, 2022
US FDA Approves Boostrix for Whooping Cough (Pertussis) Prevention in Infants Aged Younger Than Two Months
On October 07, 2022, the U.S. FDA approved GlaxoSmithKline’s Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed […]
